UNICA IRIS Institutional Research Information System

CORONA, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 271.732
NA - Nord America 11.140
AS - Asia 5.275
SA - Sud America 819
AF - Africa 186
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 289.175
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 268.862
US - Stati Uniti d'America 10.957
SG - Singapore 2.042
CN - Cina 1.703
SE - Svezia 690
BR - Brasile 615
UA - Ucraina 503
VN - Vietnam 487
DE - Germania 365
FI - Finlandia 308
FR - Francia 247
GB - Regno Unito 237
HK - Hong Kong 184
BD - Bangladesh 149
IN - India 146
BY - Bielorussia 120
CA - Canada 103
KR - Corea 93
AR - Argentina 88
NL - Olanda 84
AT - Austria 62
MA - Marocco 61
JP - Giappone 60
IQ - Iraq 55
PK - Pakistan 54
MX - Messico 52
ZA - Sudafrica 42
PL - Polonia 40
TR - Turchia 40
RU - Federazione Russa 37
ES - Italia 34
ID - Indonesia 32
IR - Iran 31
BE - Belgio 30
SA - Arabia Saudita 30
EC - Ecuador 29
CO - Colombia 26
IE - Irlanda 21
UZ - Uzbekistan 20
VE - Venezuela 20
KE - Kenya 16
PH - Filippine 16
TN - Tunisia 16
EG - Egitto 15
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
IL - Israele 13
JO - Giordania 13
AZ - Azerbaigian 12
NP - Nepal 12
AU - Australia 11
CL - Cile 11
MY - Malesia 11
DK - Danimarca 10
BO - Bolivia 9
ET - Etiopia 9
DZ - Algeria 8
GE - Georgia 8
LV - Lettonia 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
EU - Europa 7
LT - Lituania 7
HU - Ungheria 6
KG - Kirghizistan 6
NO - Norvegia 6
PT - Portogallo 6
PY - Paraguay 6
CR - Costa Rica 5
GR - Grecia 5
JM - Giamaica 4
NI - Nicaragua 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
DO - Repubblica Dominicana 3
HN - Honduras 3
LB - Libano 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
A1 - Anonimo 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
Totale 289.148
Salva come PNG Salva come JPEG
Città #
Cagliari 261.568
Uta 6.195
Singapore 1.109
Ashburn 1.103
Fairfield 842
San Jose 708
Woodbridge 702
Chandler 560
Dallas 556
Boardman 478
Nyköping 431
Houston 414
Seattle 363
Beijing 350
Wilmington 346
Ann Arbor 313
Cambridge 280
Los Angeles 262
Council Bluffs 254
New York 245
Jacksonville 226
Helsinki 207
Dearborn 190
Santa Clara 170
Hong Kong 161
Shanghai 155
The Dalles 150
Ho Chi Minh City 142
Lauterbourg 134
Hefei 117
Boston 111
Nanjing 109
Dong Ket 98
Hanoi 84
Seoul 81
Chicago 79
Rome 77
Buffalo 72
San Diego 65
Munich 61
Redwood City 61
Milan 58
São Paulo 54
Herndon 47
Casablanca 44
Tokyo 44
Vienna 42
Orem 41
Guangzhou 40
Amsterdam 38
Hangzhou 38
Redondo Beach 37
Changsha 36
London 36
Phoenix 36
Tianjin 35
Frankfurt am Main 34
Columbus 33
Toronto 33
Atlanta 32
Mountain View 32
Sassari 32
Nanchang 29
Rio de Janeiro 29
Verona 29
Washington 29
Shenyang 28
Warsaw 28
Brooklyn 27
Redmond 26
Salt Lake City 26
Chennai 25
Nuremberg 24
Jiaxing 23
Hebei 22
Lappeenranta 22
Johannesburg 21
Brussels 20
Denver 20
Montreal 20
Mumbai 20
San Francisco 20
Dublin 19
Norwalk 19
Tashkent 19
Baghdad 18
Mexico City 18
Naples 18
Gujranwala 16
Manchester 16
Ottawa 16
Curitiba 15
Lahore 15
Wuhan 15
Zhengzhou 15
Des Moines 14
Dhaka 14
Jinan 14
Nairobi 14
Pittsburgh 14
Totale 281.228
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.730
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.066
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.691
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.533
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.482
Biological activities of aerial parts extracts of Euphorbia characias 4.445
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.332
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.192
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.757
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.519
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.463
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.449
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.435
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.415
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.380
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.354
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.316
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.313
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.300
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.279
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.211
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.108
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.102
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.081
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.053
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.053
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.043
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.006
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 3.002
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.981
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.935
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.933
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.923
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.921
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.888
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.879
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.876
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.867
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.831
Insights into Ebola VP35 oligomerization from molecular simulations 2.818
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.789
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.776
null 2.746
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.736
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.713
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.659
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.641
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.621
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.574
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.466
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.441
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.432
An efficient route to novel uracil-based drug-like molecules 2.372
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.364
null 2.329
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.317
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.273
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.262
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.231
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.157
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.151
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.135
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.113
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.112
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.091
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.079
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.065
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.979
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.890
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.889
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.881
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.879
Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H 1.835
null 1.820
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.803
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.798
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function 1.725
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.711
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 1.685
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.638
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.614
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 1.586
From classic to innovative approaches in HIV-1 infection treatment 1.566
Hypericum hircinum L. components as new single molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. 1.556
Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives 1.541
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.535
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 1.459
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? 1.439
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production 1.436
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules 1.430
Peptides Mimicking the β7/β8 loop of HIV-1 Reverse Transcriptase p51 as “Hotspot-Targeted” Dimerization Inhibitors 1.420
5-arylaminouracil derivatives as potential dual-action agents 1.358
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 1.308
Natural and Nature-Derived Products Targeting Human Coronaviruses 1.302
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation 1.286
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 1.223
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.208
A combined cell based and site directed mutagenesis approach defines highly conserved residues involved in the selective inhibition of the HIV-1 ribonuclease H function by diketoacid derivatives 1.144
In Vitro Anti-HIV-1 Reverse Transcriptase and Integrase Properties of Punica granatum L. Leaves, Bark, and Peel Extracts and Their Main Compounds 1.125
The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry 1.058
Totale 262.734
Salva come PNG Salva come JPEG
Categoria #
all - tutte 349.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 349.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.790 0 0 0 0 0 0 0 0 0 0 0 1.790
2021/202215.606 1.541 1.302 877 903 1.139 1.247 897 907 1.513 1.470 1.799 2.011
2022/202326.453 2.280 3.722 3.079 2.423 1.570 2.878 1.282 1.827 1.399 1.519 2.128 2.346
2023/202424.258 1.620 862 1.324 1.822 2.331 4.147 3.191 2.097 1.158 1.331 2.071 2.304
2024/202550.727 13.089 15.338 7.484 4.880 2.332 2.847 2.652 236 492 377 448 552
2025/202612.866 877 412 1.483 1.103 1.099 795 2.189 1.149 829 1.512 913 505
Totale 289.843